Chemist + Druggist is part of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

GPhC formalises clampdown on cover-ups

The regulator has cemented its tough stance on dishonesty and failure to raise concerns in its sanctions guidance for fitness-to-practise committees

The General Pharmaceutical Council (GPhC) has placed a strong focus on tackling dishonesty in its guidance to help fitness-to-practise committees decide on sanctions.

Committees should consider sanctions at the "upper end of the scale" for professionals who deliberately avoided being candid with a patient or failed to speak out about patient safety concerns, says the GPhC guidance, unveiled on Wednesday (June 3).

The guidance will come into effect on July 20 and is based on draft proposals that were put out for consultation between February and March.

The final version of the document shows little change from the GPhC's original proposals. It cites insight into misconduct and showing remorse - either by offering an apology or attempting to put things right - as mitigating factors when deciding on sanctions, and also stipulates that removal from the register is likely to be the most appropriate sanction for cases of sexual misconduct.  

GPhC chief executive Duncan Rudkin stressed it had been important to “get the guidance right”. The feedback the regulator had received during the guidance’s consultation period had ensured the final guidance would "support good decision-making at our fitness-to-practise hearings”, he added.

Last month, the GPhC announced it would scrap an “outdated” dishonesty test from its indicative sanctions guidance, following consultation responses from the sector.

 

 


What do you think of the GPhC's focus on dishonesty?

We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information

Related Content

Topics



Pharmacist Managers - Recruiting Now !
East London, Essex and Luton
£40,000 - £50,000 per year

Apply Now
UsernamePublicRestriction

Register

CD007465

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel